查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2016206

輻射劑量管理市場：按產品、交付方式、應用和最終用戶分類－2026-2032年全球市場預測

Radiation Dose Management Market by Product, Delivery Mode, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，輻射劑量管理市場價值將達到 3.6312 億美元，到 2026 年將成長至 3.8734 億美元，到 2032 年將達到 6.1767 億美元，複合年成長率為 7.88%。

主要市場統計數據
基準年 2025 3.6312億美元
預計年份：2026年 3.8734億美元
預測年份：2032年 6.1767億美元
複合年成長率 (%) 7.88%

本文件闡明了臨床工作流程、技術整合和監管課責中輻射劑量管理的現代要求，從而提高病患安全和影像品質。

輻射劑量管理涉及病人安全、影像有效性和監管課責三者。影像硬體的進步、軟體主導的劑量監測工具的普及以及循證方案日益重要，共同建構了一個複雜的生態系統，臨床醫生、物理學家和管理人員必須通力合作，才能最佳化治療效果。本文概述了現代實踐的核心主題：整合劑量管理系統的成熟、雲端原生分析技術的興起以及對廠商互通性的日益重視，以實現持續的品質改進。

人工智慧、雲端分析和互通性的進步如何重塑輻射劑量最佳化和臨床實踐，從而推動更安全、更聰明的成像工作流程？

輻射劑量管理領域正經歷一場變革，其驅動力包括技術融合、政策日益重視以及不斷變化的臨床需求。儘管CT硬體和檢測器靈敏度的提升降低了許多掃描方案的最低可達劑量，但真正的革命在於軟體主導的劑量最佳化。人工智慧和機器學習工具正擴大應用於掃描方案選擇、影像重建和自動劑量估算，從而實現自適應成像策略，即使在較低的輻射劑量下也能保持診斷價值。

評估 2025 年美國關稅調整對劑量管理採購趨勢、供應鏈韌性和供應商服務模式的策略影響。

2025年實施的新關稅措施對輻射劑量管理生態系統中的技術應用、供應商策略和供應鏈韌性造成了直接和間接的壓力。某些零件和系統的進口成本上升迫使供應商重新評估製造地、加速本地化策略並重新協商分銷模式。對於醫療服務提供者而言，由於採購團隊需要在總擁有成本、短期資金限制和長期營運效益之間權衡，採購週期正在延長。

我們針對不同產品、輸送方式、臨床應用和最終用戶環境，識別輻射劑量管理的具體挑戰，並制定針對每種情況的實施策略。

精確理解劑量分割對於最佳化劑量管理策略以適應臨床和操作環境至關重要。根據產品類型，研究通常將產品分為服務、軟體和系統。服務包括校準、合規性、維護（對員工能力至關重要）、培訓和諮詢。軟體分為雲端部署和本地部署，反映了對集中化、延遲和資料主權的不同需求。系統進一步分為CT、乳房X光乳房X光攝影以及X光和透視設備，每種設備都有其獨特的劑量分佈和最佳化途徑。

美洲、歐洲、中東和非洲以及亞太地區的地理差異如何影響劑量管理的實施模式、監管重點和服務提供模式。

區域趨勢對輻射劑量管理領域的技術應用、監管合規和服務模式有顯著影響。在美洲，醫療機構傾向於優先考慮符合嚴格監管報告和認證要求的整合解決方案，而公立和私人保險公司則越來越重視可驗證的安全性能。這推動了對可互操作系統、全面維護合約以及支援臨床管治和營運效率的分析能力的需求。大都會圈的領先醫療中心往往是推動新型劑量最佳化技術應用的催化劑。

競爭格局分析，重點在於那些將設備創新、互通軟體和強大的服務模式相結合，以促進輻射安全和營運彈性的供應商。

輻射劑量管理生態系統中的主要企業正在部署一系列整合系統、專用軟體和服務，優先考慮安全性、互通性和全生命週期支援。市場領導者正加大研發投入，以推進劑量降低技術、整合人工智慧驅動的重建演算法並增強遠端監控能力，從而減少停機時間並提高校準精度。系統製造商、軟體供應商和服務供應商之間的策略夥伴關係正成為提供端到端解決方案的常見方式，這些解決方案將設備級控制與企業級分析相結合。

為了最佳化輻射劑量管理，醫療保健管理者需要採取切實可行的、優先的行動，協調採購、訓練、互通性和管治。

業界領導者必須推動一系列切實可行的舉措，以加速醫療機構輻射劑量管理的實質改進。優先投資於員工培訓和系統諮詢至關重要，這有助於將劑量意識融入日常影像工作流程，並支援持續改善操作規程。培訓項目應著重實用性，並針對具體職位進行調整，同時透過能力評估和定期審核來強化訓練效果。

採用綜合混合方法研究方法，結合專家訪談、技術評估和監管分析，以支持研究結果的檢驗和實際應用。

本研究採用混合方法，結合質性專家訪談、技術評估、監管審查和二手文獻整合，以確保方法的嚴謹性和有效性。關鍵輸入包括對臨床負責人、醫學物理學家、影像技師和採購負責人的結構化訪談，以收集關於可用性、培訓需求和操作限制的實際觀點。這些見解與產品文件、臨床指南和同行評審的研究進行交叉比對，以檢驗技術聲明和性能特徵。

將策略重點和實際途徑結合，使輻射劑量管理成為臨床品質、安全和營運韌性的永續組成部分。

輻射劑量管理如今已成為一項策略性挑戰，它關係到臨床品質、病人安全和組織韌性。先進成像硬體、人工智慧驅動的最佳化以及可擴展的分析技術的整合，為在維持和提升診斷效果的同時減少不必要的輻射暴露提供了契機。然而，要充分發揮這一潛力，需要重視人力資源發展、互通性、生命週期服務模式以及能夠保護病患資料並確保合規性的管治框架。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 輻射劑量管理市場：依產品分類

  • 服務
    • 維護
    • 培訓和諮詢
  • 軟體
    • 雲
    • 現場
  • 系統
    • CT
    • 乳房X光攝影
    • X光和透視

第9章：輻射劑量管理市場：依交付模式分類

  • 雲
  • 現場

第10章 輻射劑量管理市場：依應用領域分類

  • 牙科影像
  • 診斷影像
  • 介入治療
  • 放射治療

第11章 輻射劑量管理市場：依最終用戶分類

  • 診所
  • 診斷中心
  • 醫院
  • 研究機構

第12章：輻射劑量管理市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：輻射劑量管理市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 輻射劑量管理市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國輻射劑量管理市場

第16章：中國輻射劑量管理市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agfa HealthCare NV
  • Bayer AG
  • Bracco Imaging SpA
  • Canon Inc.
  • FUJIFILM Holdings Corporation
  • GE HealthCare LLC
  • Guerbet SA
  • INFINITT Healthcare Co., Ltd.
  • Koninklijke Philips NV
  • Landauer, Inc.
  • Medsquare SA
  • Mirion Technologies, Inc.
  • Novarad Corporation
  • PACSHealth, LLC
  • Siemens Healthineers AG
Product Code: MRR-035AB9C0DA67

The Radiation Dose Management Market was valued at USD 363.12 million in 2025 and is projected to grow to USD 387.34 million in 2026, with a CAGR of 7.88%, reaching USD 617.67 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 363.12 million
Estimated Year [2026] USD 387.34 million
Forecast Year [2032] USD 617.67 million
CAGR (%) 7.88%

Framing the contemporary imperative for radiation dose management across clinical workflows, technology convergence, and regulatory accountability to enhance patient safety and imaging quality

Radiation dose management sits at the intersection of patient safety, imaging efficacy, and regulatory accountability. Advances in imaging hardware, the proliferation of software-driven dose monitoring tools, and the increasing emphasis on evidence-based protocols have created a complex ecosystem where clinicians, physicists, and administrators must collaborate to optimize outcomes. This introduction outlines the core themes that underpin contemporary practice: the maturation of integrated dose management systems, the rise of cloud-native analytics, and the intensifying focus on cross-vendor interoperability to enable continuous quality improvement.

Within clinical environments, the practical imperative is clear: reduce unnecessary exposure while preserving diagnostic confidence. This necessitates converging investments in staff training, robust maintenance programs, and software solutions that deliver real-time feedback. Meanwhile, vendor strategies are evolving to embed dose tracking within broader imaging informatics platforms, enabling longitudinal patient dose histories and population-level analytics. The pace of innovation is matched by evolving standards and guidelines that emphasize transparency, documentation, and actionable alerts when thresholds are exceeded.

Consequently, leaders in healthcare delivery and medical technology must balance technological possibilities with operational realities. This report provides a foundation for understanding where emerging technologies can be deployed for maximal clinical benefit, where workflow redesign is required, and how stakeholders can collaborate to sustain improvements in radiation safety and diagnostic quality.

How advances in AI, cloud analytics, and interoperability are reshaping radiation dose optimization and clinical practice to drive safer, smarter imaging workflows

The landscape of radiation dose management is undergoing transformative shifts driven by technological convergence, policy emphasis, and changing clinical expectations. Advancements in CT hardware and detector sensitivity have reduced the minimum achievable dose for many protocols, yet the real revolution lies in software-driven dose optimization. Artificial intelligence and machine learning tools are increasingly applied to protocol selection, image reconstruction, and automated dose estimation, enabling adaptive imaging strategies that maintain diagnostic value at lower exposure levels.

Simultaneously, the migration of analytics to cloud architectures has unlocked scalable population-level insights, permitting longitudinal dose tracking across institutions and care episodes. This shift supports benchmarking, trend analysis, and predictive maintenance programs that reduce unplanned downtime and preserve calibration integrity. Interoperability standards and APIs are maturing, facilitating the integration of dose monitoring into electronic health records and vendor-neutral archives, which bolsters clinical decision support and recordkeeping.

In parallel, workforce competencies are adapting. Radiographers, medical physicists, and radiologists increasingly require fluency with dose analytics, protocol governance, and change management practices. Training and consultancy services are expanding to meet these needs, emphasizing practical implementation, audit readiness, and cultural change toward dose awareness. Taken together, these transformative forces are reshaping how institutions approach safety, efficiency, and accountability in medical imaging.

Assessing the strategic consequences of United States tariff adjustments in 2025 on procurement dynamics, supply chain resilience, and vendor service models in dose management

The introduction of new tariff policies in the United States in 2025 has introduced direct and indirect pressures on technology acquisition, supplier strategies, and supply chain resilience within the radiation dose management ecosystem. Increased import costs for certain components and systems have incentivized vendors to reassess manufacturing footprints, accelerate localization strategies, and renegotiate distribution models. For healthcare providers, procurement cycles have lengthened as purchasing teams weigh total cost of ownership against immediate capital constraints and long-term operational benefits.

Regulatory and reimbursement frameworks have responded by placing greater emphasis on demonstrable value and lifecycle support. Organizations are prioritizing solutions that offer robust maintenance plans, remote diagnostics, and software upgrades that can extend equipment longevity and mitigate the need for frequent capital replacement. Cloud-based software licensing models and service contracts have become more attractive as they decouple upfront hardware costs from ongoing analytics and support, though they require due diligence around data governance and cybersecurity.

Vendors and providers alike are exploring alternative pathways to manage tariff impacts, such as strategic partnerships, regional service hubs, and modular upgrade offerings that isolate high-cost components from the overall system. These adaptations reflect a broader shift toward resilience and flexibility, ensuring that the capacity to deliver safe, high-quality imaging services remains intact despite external economic pressures.

Segment-specific imperatives in radiation dose management across products, delivery modes, clinical applications, and end-user settings to guide tailored adoption strategies

A nuanced understanding of segmentation is essential for tailoring dose management strategies to clinical and operational contexts. Based on product, studies typically classify offerings across services, software, and system categories. Services encompass maintenance and training and consultancy, which are critical for sustaining calibration, compliance, and staff competency. Software divides into cloud-based and on-premise deployments, reflecting divergent needs for centralization, latency, and data sovereignty. Systems are further categorized into CT, mammography, and X-ray and fluoroscopy, each with unique dose profiles and optimization pathways.

Based on delivery mode, distinctions between cloud-based and on-premise solutions determine integration complexity, data stewardship responsibilities, and scalability potential. Cloud-based offerings accelerate population-level analytics and centralized updates but require mature cybersecurity and consent frameworks. On-premise deployments provide tighter control over data residency and may better suit institutions with constrained connectivity or heightened regulatory requirements.

Based on application, clinical use cases span dental imaging, diagnostic imaging, interventional procedures, and radiotherapy, each demanding bespoke dose tracking, protocol optimization, and outcome measurement. Dental imaging often focuses on focused low-dose protocols and pediatric considerations, while interventional procedures require real-time dose monitoring and operator alerts. Radiotherapy integrates dosimetry with treatment planning systems, necessitating high-precision measurements and harmonized workflows.

Based on end user, the typical settings include clinics, diagnostic centers, hospitals, and research institutes, each with different purchasing dynamics, operational scale, and regulatory expectations. Clinics and diagnostic centers prioritize cost-effective, easy-to-deploy solutions that minimize disruption. Hospitals demand enterprise-scale interoperability and comprehensive maintenance programs. Research institutes focus on experimental flexibility and data fidelity to support innovation and validation studies.

How geographic variations across Americas, Europe Middle East & Africa, and Asia-Pacific influence adoption patterns, regulatory priorities, and service delivery models in dose management

Regional dynamics profoundly shape technology adoption, regulatory alignment, and service delivery models in radiation dose management. In the Americas, institutions tend to prioritize integrated solutions that align with stringent regulatory reporting and accreditation requirements, while private and public payers increasingly reward demonstrable safety performance. This drives demand for interoperable systems, comprehensive maintenance contracts, and analytics that support both clinical governance and operational efficiency. Centers of excellence in large metropolitan areas often serve as catalysts for diffusion of novel dose-optimization practices.

In Europe, Middle East & Africa, the landscape is heterogeneous, with high-resource healthcare systems pushing rapid adoption of cloud analytics, advanced CT protocols, and cross-institutional benchmarking. Meanwhile, emerging markets within the region emphasize cost-effective maintenance, localized training, and solutions that can operate in variable infrastructure environments. Regional regulatory bodies and professional societies are intensifying guideline harmonization efforts, which supports broader uptake of standardized dose-tracking approaches.

In Asia-Pacific, rapid expansion of imaging capacity combined with investment in digital health infrastructure is accelerating uptake of both hardware upgrades and software-driven dose management tools. Government-led modernization programs and large-scale hospital networks are adopting centralized analytics and population-level safety initiatives. However, deployment strategies must account for wide variability in clinical practice standards, IT maturity, and workforce training needs to ensure equitable improvements in radiation safety across urban and rural settings.

Competitive landscape analysis emphasizing providers that combine device innovation, interoperable software, and robust service models to advance radiation safety and operational resilience

Key companies shaping the radiation dose management ecosystem deploy a mix of integrated systems, specialized software, and service offerings that emphasize safety, interoperability, and lifecycle support. Market leaders invest in research and development to advance dose reduction techniques, integrate AI-enhanced reconstruction algorithms, and expand remote monitoring capabilities that reduce downtime and improve calibration accuracy. Strategic partnerships between system manufacturers, software vendors, and service providers have become a common route to delivering end-to-end solutions that combine device-level controls with enterprise analytics.

Competitive differentiation increasingly resides in the ability to provide validated clinical workflows, robust training programs, and evidence of successful deployments across diverse clinical environments. Companies that offer modular upgrade paths and vendor-neutral integration capabilities enable healthcare organizations to protect prior investments while modernizing their dose management practices. Additionally, firms that demonstrate clear governance frameworks for data privacy, security, and compliance gain trust among enterprise buyers and health system risk managers.

Smaller, specialized vendors continue to innovate rapidly in niche areas such as pediatric dose optimization, interventional dose monitoring, and cloud-based longitudinal dose registries. These firms often partner with larger system manufacturers to scale distribution and certification efforts. Overall, the competitive landscape rewards a balance of clinical credibility, technical interoperability, and scalable service delivery.

Practical and prioritized actions for healthcare executives to align procurement, training, interoperability, and governance in pursuit of optimized radiation dose management

Industry leaders must pursue a portfolio of actionable initiatives to accelerate meaningful improvements in radiation dose management across institutions. First, prioritize investments in staff training and structured consultancy that embed dose-awareness into everyday imaging workflows and support continuous protocol refinement. Training programs should be hands-on, role-specific, and reinforced through competency assessments and periodic audits.

Second, adopt an interoperability-first procurement posture that favors solutions with open APIs and standardized data models to facilitate integration with electronic health records and vendor-neutral archives. This reduces vendor lock-in and enables enterprise-wide dose governance. Third, consider hybrid deployment strategies that leverage cloud-based analytics for population-level insights while retaining on-premise controls where data residency or latency concerns are paramount.

Fourth, negotiate service agreements that emphasize preventive maintenance, remote diagnostics, and software update pathways to extend equipment life and reduce unplanned downtime. Fifth, implement robust governance mechanisms for data security, patient consent, and audit trails to maintain trust and compliance. Finally, embed cross-disciplinary leadership teams-comprising radiology, medical physics, IT, and procurement-to ensure that technology adoption aligns with clinical objectives, budgetary constraints, and regulatory responsibilities.

Comprehensive mixed-methods research approach combining expert interviews, technology assessments, and regulatory analysis to validate findings and support practical implementation

This research leverages a mixed-methods approach combining qualitative expert interviews, technology assessments, regulatory reviews, and secondary literature synthesis to ensure methodological rigor and relevance. Primary inputs include structured interviews with clinical leaders, medical physicists, imaging technologists, and procurement specialists to capture frontline perspectives on usability, training needs, and operational constraints. These insights are cross-referenced with product documentation, clinical guidelines, and peer-reviewed studies to validate technical claims and performance characteristics.

Technology evaluations examine system-level architecture, software deployment modalities, and integration capabilities with existing health IT infrastructure. Regulatory and standards reviews focus on regional guidance, reporting expectations, and accreditation criteria that influence adoption decisions. The methodology places particular emphasis on triangulation: findings from interviews are compared against vendor documentation and published evidence to reduce bias and ensure balanced representation of strengths and limitations.

To preserve transparency, methodological limitations and data provenance are documented, and recommendations are framed to reflect practical feasibility. Stakeholders are encouraged to use the methodological appendix to tailor the findings to their own organizational contexts and to request supplementary analyses where more granular segmentation or regional specificity is required.

Synthesis of strategic priorities and practical pathways to embed radiation dose management as a sustained component of clinical quality, safety, and operational resilience

Radiation dose management is now a strategic imperative that spans clinical quality, patient safety, and institutional resilience. The convergence of advanced imaging hardware, AI-enabled optimization, and scalable analytics presents an opportunity to reduce unnecessary exposure while preserving or enhancing diagnostic outcomes. Yet realizing this potential requires deliberate attention to workforce development, interoperability, lifecycle service models, and governance frameworks that protect patient data and ensure regulatory compliance.

Organizations that succeed will be those that adopt a systems perspective: integrating device-level controls with enterprise analytics, embedding training and maintenance into procurement decisions, and aligning technology choices with clinical workflows. Regional variability and economic pressures call for adaptable procurement strategies that balance upfront costs with long-term value in safety, uptime, and clinical performance. Ultimately, by prioritizing actionable measurement, cross-disciplinary collaboration, and continuous improvement, healthcare providers can deliver imaging services that are safer, more efficient, and more trustworthy for patients and clinicians alike.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Radiation Dose Management Market, by Product

  • 8.1. Services
    • 8.1.1. Maintenance
    • 8.1.2. Training And Consultancy
  • 8.2. Software
    • 8.2.1. Cloud-Based
    • 8.2.2. On-Premise
  • 8.3. System
    • 8.3.1. Ct
    • 8.3.2. Mammography
    • 8.3.3. X-Ray And Fluoroscopy

9. Radiation Dose Management Market, by Delivery Mode

  • 9.1. Cloud-Based
  • 9.2. On-Premise

10. Radiation Dose Management Market, by Application

  • 10.1. Dental Imaging
  • 10.2. Diagnostic Imaging
  • 10.3. Interventional Procedures
  • 10.4. Radiotherapy

11. Radiation Dose Management Market, by End User

  • 11.1. Clinics
  • 11.2. Diagnostic Centers
  • 11.3. Hospitals
  • 11.4. Research Institutes

12. Radiation Dose Management Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Radiation Dose Management Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Radiation Dose Management Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Radiation Dose Management Market

16. China Radiation Dose Management Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Agfa HealthCare NV
  • 17.6. Bayer AG
  • 17.7. Bracco Imaging S.p.A.
  • 17.8. Canon Inc.
  • 17.9. FUJIFILM Holdings Corporation
  • 17.10. GE HealthCare LLC
  • 17.11. Guerbet SA
  • 17.12. INFINITT Healthcare Co., Ltd.
  • 17.13. Koninklijke Philips N.V.
  • 17.14. Landauer, Inc.
  • 17.15. Medsquare SA
  • 17.16. Mirion Technologies, Inc.
  • 17.17. Novarad Corporation
  • 17.18. PACSHealth, LLC
  • 17.19. Siemens Healthineers AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL RADIATION DOSE MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL RADIATION DOSE MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES RADIATION DOSE MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA RADIATION DOSE MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY TRAINING AND CONSULTANCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY TRAINING AND CONSULTANCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY TRAINING AND CONSULTANCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY CLOUD-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY CLOUD-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY ON-PREMISE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY MAMMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY MAMMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY MAMMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY X-RAY AND FLUOROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY X-RAY AND FLUOROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY X-RAY AND FLUOROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY CLOUD-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY CLOUD-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY ON-PREMISE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY DENTAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY DENTAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY DENTAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY INTERVENTIONAL PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY INTERVENTIONAL PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY INTERVENTIONAL PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY RADIOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY RADIOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS RADIATION DOSE MANAGEMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GCC RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GCC RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 145. GCC RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 146. GCC RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 147. GCC RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 148. GCC RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 149. GCC RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. GCC RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. G7 RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. G7 RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 169. G7 RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 170. G7 RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 171. G7 RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 172. G7 RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 173. G7 RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. G7 RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. NATO RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. NATO RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 177. NATO RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 178. NATO RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 179. NATO RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 180. NATO RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 181. NATO RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. NATO RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES RADIATION DOSE MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA RADIATION DOSE MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)